El-Laithy H.M.; Badawi A.; Abdelmalak N.S.; Elsayyad N.M.E.
(Elsevier B.V., 2019)
Clopidogrel bisulfate (CB) is a golden antiplatelet treatment, yet its benefits are limited by its low bioavailability (<50%) caused by poor intestinal solubility and absorption. The present study aims to improve CB ...